PubRank

Matthias Blüher

Author PubWeight™ 205.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008 12.41
2 Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006 9.53
3 T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008 5.44
4 Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A 2009 5.19
5 Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 2010 5.01
6 Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A 2006 4.81
7 Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial. Ann Intern Med 2015 3.78
8 Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010 3.46
9 A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 2012 3.35
10 Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007 2.81
11 Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 2007 2.69
12 Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2007 2.48
13 Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005 2.34
14 Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia 2015 2.25
15 Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet 2013 2.10
16 Serum levels of the adipokine progranulin depend on renal function. Diabetes Care 2012 2.03
17 Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes 2008 1.97
18 Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2007 1.96
19 Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004 1.92
20 Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care 2007 1.85
21 MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One 2009 1.81
22 Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine. Diabetes 2012 1.76
23 Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol 2006 1.76
24 Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care 2006 1.63
25 Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction. Clin Endocrinol (Oxf) 2014 1.49
26 Altered autophagy in human adipose tissues in obesity. J Clin Endocrinol Metab 2010 1.47
27 Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care 2008 1.42
28 Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes 2008 1.42
29 Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2005 1.30
30 Dietary intervention to reverse carotid atherosclerosis. Circulation 2010 1.28
31 Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS One 2010 1.25
32 Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genet 2010 1.22
33 Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 2011 1.20
34 Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2007 1.19
35 Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease. Atherosclerosis 2007 1.18
36 Genetic variation in GPR133 is associated with height: genome wide association study in the self-contained population of Sorbs. Hum Mol Genet 2009 1.16
37 Positional cloning of zinc finger domain transcription factor Zfp69, a candidate gene for obesity-associated diabetes contributed by mouse locus Nidd/SJL. PLoS Genet 2009 1.15
38 Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training. Eur J Endocrinol 2009 1.14
39 Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord 2014 1.12
40 Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes 2007 1.12
41 Long-term exercise training decreases interleukin-6 (IL-6) serum levels in subjects with impaired glucose tolerance: effect of the -174G/C variant in IL-6 gene. Eur J Endocrinol 2008 1.11
42 Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 2011 1.11
43 Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity. Diabetes 2009 1.11
44 Molecular characteristics of serum visfatin and differential detection by immunoassays. J Clin Endocrinol Metab 2007 1.11
45 Implication of progranulin and C1q/TNF-related protein-3 (CTRP3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome. PLoS One 2013 1.10
46 Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity? J Clin Endocrinol Metab 2012 1.10
47 Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis 2008 1.08
48 Genomic insights into the origin of farming in the ancient Near East. Nature 2016 1.07
49 Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clin Endocrinol (Oxf) 2008 1.07
50 Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections. PLoS One 2010 1.06
51 Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochem Biophys Res Commun 2005 1.06
52 Extended longevity and insulin signaling in adipose tissue. Exp Gerontol 2005 1.06
53 Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology 2007 1.06
54 Local proliferation of macrophages in adipose tissue during obesity-induced inflammation. Diabetologia 2013 1.05
55 The ARF-like GTPase ARFRP1 is essential for lipid droplet growth and is involved in the regulation of lipolysis. Mol Cell Biol 2009 1.03
56 Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care 2013 1.03
57 Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance. Diabetes 2010 1.02
58 Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. Nat Med 2013 1.02
59 Pro-inflammatory macrophages increase in skeletal muscle of high fat-fed mice and correlate with metabolic risk markers in humans. Obesity (Silver Spring) 2013 1.01
60 Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity. PLoS One 2012 1.01
61 Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. J Clin Endocrinol Metab 2006 1.01
62 Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond) 2008 1.00
63 Serum levels of the adipokine zinc-α2-glycoprotein are increased in chronic hemodialysis. Metabolism 2010 0.99
64 The genetics of fat distribution. Diabetologia 2014 0.99
65 Serum levels of the myokine irisin in relation to metabolic and renal function. Eur J Endocrinol 2014 0.99
66 Clinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes? Diabetes Ther 2014 0.98
67 Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care 2013 0.97
68 Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J Clin Endocrinol Metab 2014 0.96
69 Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism 2009 0.96
70 Adipose tissue foam cells are present in human obesity. J Clin Endocrinol Metab 2013 0.96
71 Dairy calcium intake, serum vitamin D, and successful weight loss. Am J Clin Nutr 2010 0.95
72 Defining the human adipose tissue proteome to reveal metabolic alterations in obesity. J Proteome Res 2014 0.94
73 Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care 2009 0.93
74 An inflammatory micro-environment promotes human adipocyte apoptosis. Mol Cell Endocrinol 2011 0.93
75 Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients. Am J Hypertens 2010 0.93
76 Evaluation of a computer based interactive diabetes education program designed to train the estimation of the energy or carbohydrate contents of foods. Patient Educ Couns 2002 0.92
77 The adipokine SAA3 is induced by interleukin-1beta in mouse adipocytes. J Cell Biochem 2008 0.91
78 Lack of association between the tagging SNP A+930-->G of SOCS3 and type 2 diabetes mellitus: meta-analysis of four independent study populations. PLoS One 2008 0.91
79 Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy. Regul Pept 2011 0.91
80 Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 (BMPR2) in the pathophysiology of obesity. PLoS One 2011 0.90
81 Loss of function of Ifi202b by a microdeletion on chromosome 1 of C57BL/6J mice suppresses 11β-hydroxysteroid dehydrogenase type 1 expression and development of obesity. Hum Mol Genet 2012 0.89
82 Quantitative measurement of full-length and C-terminal proteolyzed RBP4 in serum of normal and insulin-resistant humans using a novel mass spectrometry immunoassay. Endocrinology 2012 0.89
83 Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Lett 2004 0.88
84 Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr 2010 0.88
85 Amyloid precursor protein expression is induced by tumor necrosis factor alpha in 3T3-L1 adipocytes. J Cell Biochem 2009 0.88
86 Circulating chemerin decreases in response to a combined strength and endurance training. Endocrine 2013 0.88
87 Dimerization of adiponectin receptor 1 is inhibited by adiponectin. J Cell Sci 2010 0.88
88 TCF7L2 gene expression in human visceral and subcutaneous adipose tissue is differentially regulated but not associated with type 2 diabetes mellitus. Metabolism 2008 0.88
89 The polygenetically inherited metabolic syndrome of WOKW rats is associated with insulin resistance and altered gene expression in adipose tissue. Diabetes Metab Res Rev 2006 0.87
90 Effects of extended-release niacin on lipid profile and adipocyte biology in patients with impaired glucose tolerance. Atherosclerosis 2008 0.87
91 Long- but not short-term multifactorial intervention with focus on exercise training improves coronary endothelial dysfunction in diabetes mellitus type 2 and coronary artery disease. Eur Heart J 2009 0.86
92 Role of genetic variation in the cannabinoid type 1 receptor gene (CNR1) in the pathophysiology of human obesity. Pharmacogenomics 2010 0.86
93 Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol 2008 0.86
94 Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis. Metabolism 2008 0.86
95 Endocrine disrupting chemicals affect the adipogenic differentiation of mesenchymal stem cells in distinct ontogenetic windows. Biochem Biophys Res Commun 2011 0.85
96 Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver disease. Curr Pharm Des 2010 0.85
97 Carbonylated plasma proteins as potential biomarkers of obesity induced type 2 diabetes mellitus. J Proteome Res 2014 0.85
98 Predictive accuracy of single- and multi-slice MRI for the estimation of total visceral adipose tissue in overweight to severely obese patients. NMR Biomed 2015 0.85
99 Software for automated MRI-based quantification of abdominal fat and preliminary evaluation in morbidly obese patients. J Magn Reson Imaging 2012 0.84
100 Regenerative capacity differs between micro- and macrovesicular hepatic steatosis. Exp Toxicol Pathol 2007 0.84
101 Vaspin inhibits kallikrein 7 by serpin mechanism. Cell Mol Life Sci 2013 0.84
102 Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis. Metabolism 2009 0.83
103 COL6A3 expression in adipocytes associates with insulin resistance and depends on PPARγ and adipocyte size. Obesity (Silver Spring) 2014 0.83
104 Association of glypican-4 with body fat distribution, insulin resistance, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2013 0.83
105 Shox2 is a molecular determinant of depot-specific adipocyte function. Proc Natl Acad Sci U S A 2013 0.83
106 Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes Facts 2013 0.83
107 Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism 2009 0.83
108 R1467H variant in the rho guanine nucleotide exchange factor 11 (ARHGEF11) is associated with impaired glucose tolerance and type 2 diabetes in German Caucasians. J Hum Genet 2008 0.83
109 Circulating anandamide and blood pressure in patients with obstructive sleep apnea. J Hypertens 2012 0.82
110 Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans. J Endocrinol 2013 0.82
111 Association between plasma nonesterified fatty acids species and adipose tissue fatty acid composition. PLoS One 2013 0.82
112 Genetic and biochemical evidence for a functional role of BACE1 in the regulation of insulin mRNA expression. Obesity (Silver Spring) 2013 0.82
113 Beneficial effects of a 4-week exercise program on plasma concentrations of adhesion molecules. Diabetes Care 2007 0.82
114 Global DNA methylation levels in human adipose tissue are related to fat distribution and glucose homeostasis. Diabetologia 2014 0.82
115 Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia. Cytokine 2013 0.81
116 Repin1 maybe involved in the regulation of cell size and glucose transport in adipocytes. Biochem Biophys Res Commun 2010 0.81
117 Short-term changes of the urine metabolome after bariatric surgery. OMICS 2012 0.81
118 Serum vaspin concentrations are decreased after exercise-induced oxidative stress. Obes Facts 2010 0.81
119 Autophagy in adipose tissue. Obes Facts 2012 0.81
120 COMP-angiopoietin-1 recovers molecular biomarkers of neuropathy and improves vascularisation in sciatic nerve of ob/ob mice. PLoS One 2012 0.81
121 Role of vaspin in human eating behaviour. PLoS One 2013 0.81
122 Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome. J Neurosci Res 2011 0.81
123 C57BL/6JRj mice are protected against diet induced obesity (DIO). Biochem Biophys Res Commun 2011 0.81
124 Defective peripheral nerve development is linked to abnormal architecture and metabolic activity of adipose tissue in Nscl-2 mutant mice. PLoS One 2009 0.81
125 Benefits of foods supplemented with vegetable oils rich in α-linolenic, stearidonic or docosahexaenoic acid in hypertriglyceridemic subjects: a double-blind, randomized, controlled trail. Eur J Nutr 2014 0.81
126 Does retinol-binding protein 4 cause or reflect fatty liver disease? Hepatology 2008 0.80
127 Glycation sites of human plasma proteins are affected to different extents by hyperglycemic conditions in type 2 diabetes mellitus. Anal Bioanal Chem 2014 0.80
128 Access to gram scale amounts of functional globular adiponectin from E. coli inclusion bodies by alkaline-shock solubilization. Biochem Biophys Res Commun 2010 0.80
129 Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function. Eur J Endocrinol 2008 0.80
130 Nicotinamide nucleotide transhydrogenase mRNA expression is related to human obesity. Obesity (Silver Spring) 2013 0.80
131 Adipose tissue depot specific promoter methylation of TMEM18. J Mol Med (Berl) 2014 0.80
132 An ACACB variant implicated in diabetic nephropathy associates with body mass index and gene expression in obese subjects. PLoS One 2013 0.80
133 A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic pancreatitis. PLoS One 2012 0.79
134 Fas (CD95) expression in myeloid cells promotes obesity‐induced muscle insulin resistance. EMBO Mol Med 2014 0.79
135 Insulin administration acutely decreases vaspin serum concentrations in humans. Obes Facts 2013 0.79
136 SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity. J Clin Invest 2016 0.79
137 TSH compensates thyroid-specific IGF-I receptor knockout and causes papillary thyroid hyperplasia. Mol Endocrinol 2011 0.78
138 Complete analysis of the human mesotrypsinogen gene (PRSS3) in patients with chronic pancreatitis. Pancreatology 2010 0.78
139 Exercise training restores the endothelial response to vascular growth factors in patients with stable coronary artery disease. Eur J Prev Cardiol 2011 0.78
140 Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia. Am J Hypertens 2008 0.78
141 Vaspin--a link of obesity and psoriasis? Exp Dermatol 2012 0.78
142 Adiponectin promotes the migration of circulating angiogenic cells through p38-mediated induction of the CXCR4 receptor. Int J Cardiol 2012 0.78
143 Effect of genetic variation in the human fatty acid synthase gene (FASN) on obesity and fat depot-specific mRNA expression. Obesity (Silver Spring) 2009 0.78
144 Genetic analyses of heme oxygenase 1 (HMOX1) in different forms of pancreatitis. PLoS One 2012 0.78
145 Differential expression of novel adiponectin receptor-1 transcripts in skeletal muscle of subjects with normal glucose tolerance and type 2 diabetes. Diabetes 2011 0.78
146 Efficacy and safety of the weight-loss drug rimonabant. Lancet 2008 0.77
147 Mutational analysis of the gene encoding the zymogen granule membrane glycoprotein 2 (GP2) in patients with chronic pancreatitis. Pancreas 2010 0.77
148 Preliminary report: Serum levels of retinol-binding protein 4 in preeclampsia. Metabolism 2009 0.77
149 Reduced food intake and body weight in mice deficient for the G protein-coupled receptor GPR82. PLoS One 2011 0.77
150 Effects of supervised vs non-supervised combined aerobic and resistance exercise programme on cardiometabolic risk factors. Cent Eur J Public Health 2013 0.77
151 Circulating Nampt and RBP4 levels in patients with carotid stenosis undergoing carotid endarterectomy (CEA). Clin Chim Acta 2011 0.76
152 Sequence analysis of the human tyrosylprotein sulfotransferase-2 gene in subjects with chronic pancreatitis. Pancreatology 2010 0.76
153 Effects of isoflurane anesthesia on F-waves in the sciatic nerve of the adult rat. Muscle Nerve 2014 0.76
154 PACAP up-regulates the expression of apolipoprotein D in 3T3-L1 adipocytes. DRG/3T3-L1 co-cultures study. Neurosci Res 2010 0.76
155 Dietary intervention induces flow of changes within biomarkers of lipids, inflammation, liver enzymes, and glycemic control. Nutrition 2011 0.76
156 High baseline vitamin C levels do not prevent a positive outcome of a lifestyle intervention: response to Thamer et al. Diabetes Care 2010 0.76
157 Analysis of a rare functional truncating mutation rs61757459 in vaspin (SERPINA12) on circulating vaspin levels. J Mol Med (Berl) 2013 0.75
158 Management of nicotinamide N-methyltransferase overexpression: inhibit the enzyme or reduce nicotinamide intake? Reply to Zhou S, Li D, Zhou Y [letter]. Diabetologia 2015 0.75
159 Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet 2016 0.75
160 Comparison of T1 relaxation times in adipose tissue of severely obese patients and healthy lean subjects measured by 1.5 T MRI. NMR Biomed 2014 0.75
161 Serum levels of growth arrest specific protein 6 are increased in preeclampsia. Regul Pept 2013 0.75
162 Efficacy and Safety of Cathine (Nor-Pseudoephedrine) in the Treatment of Obesity: A Randomized Dose-Finding Study. Obes Facts 2017 0.75
163 [Practical aspects in the use of biosimilar insulins]. Dtsch Med Wochenschr 2016 0.75
164 Corrigendum: The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue. Nat Med 2017 0.75
165 Serum levels of adipocyte fatty acid-binding protein are decreased in chronic pancreatitis. Pancreas 2012 0.75
166 Plasminogen activator inhibitor-1 expression and secretion are stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. Mol Cell Endocrinol 2006 0.75
167 Effects of a 2-y dietary weight-loss intervention on cholesterol metabolism in moderately obese men. Am J Clin Nutr 2011 0.75